학술논문
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
Document Type
Article
Author
Aygören-Pürsün, E.; Zanichelli, A.; Cohn, D.M.; Cancian, M.; Hakl, R.; Kinaciyan, T.; Magerl, M.; Maurer, M.; Martinez-Saguer, I.; Stobiecki, M.; Farkas, H.; Kiani-Alikhan, S.; Grivcheva-Panovska, V.; Bernstein, J.A.; Li, H.H.; Longhurst, H.J.; Yea, C.M.; Audhya, P.K.; Smith, M.D.; Maetzel, A.; Lee, D.K.; Feener, E.P.; Gower, R.; Lumry, W.R.; Banerji, A.; Riedl, M.A.
Source
In: The Lancet . (The Lancet, 11 February 2023, 401(10375):458-469)
Subject
Language
English
ISSN
1474547X
01406736
01406736